Ionis Pharmaceuticals in (ions 0 04/01/26)
13F holders, Q3 2024 (September 30)10holders +1
3new positions
2sold out
$0.99avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Ionis Pharmaceuticals in (ions 0 04/01/26) in their 13F filings, up 1 from Q2 2024. 3 opened new positions and 2 sold out. The largest holders were Sonora Investment Management Group, LLC ($12.2M), New York State Common Retirement Fund ($2.4M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($495K).
- Company
- Ionis Pharmaceuticals in (ions 0 04/01/26)
- CUSIP
- 462222AD2
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $2.5M |
| Exits | 2 | $6.5M |
All 13F filers, Q2 2024 → Q3 2024: 2,505,000 shares bought and 6,822,000 shares sold, net −4,317,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Sonora Investment Management Group, LLC | 0.92% | Reduce -1.2% | 12,363,000 | $12.2M |
| New York State Common Retirement Fund | 0.00% | New | 2,442,000 | $2.4M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 500,000 | $495K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $299K |
| Jane Street Group, LLC | 0.00% | Reduce -73.4% | 145,000 | $144K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -4.8% | 98,000 | $98K |
| Boussard & Gavaudan Investment Management LLP | 0.01% | New | 55,000 | $55K |
| Choreo, LLC | 0.00% | Add +11.9% | 47,000 | $47K |
| Stephens Inc. | 0.00% | Reduce -6.3% | 45,000 | $45K |
| Comerica Bank | 0.00% | New | 3,000 | $3K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0 04/01/26)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0 04/01/26) the manager owns.